A

Modulating CRISPR-Cas Genome Editing Using Guide-Complementary DNA Oligonucleotides

The CRISPR Journal, vol. 5, pp. 571–585

Abstract

Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) has revolutionized genome editing and has great potential for many applications, such as correcting human genetic disorders. To increase the safety of genome editing applications, CRISPR-Cas may benefit from strict control over Cas enzyme activity. Previously, anti-CRISPR proteins and designed oligonucleotides have been proposed to modulate CRISPR-Cas activity. In this study, we report on the potential of guide-complementary DNA oligonucleotides as controlled inhibitors of Cas9 ribonucleoprotein complexes. First, we show that DNA oligonucleotides inhibit Cas9 activity in human cells, reducing both on- and off-target cleavage. We then used in vitro assays to better understand how inhibition is achieved and under which conditions. Two factors were found to be important for robust inhibition: the length of the complementary region and the presence of a protospacer adjacent motif-loop on the inhibitor. We conclude that DNA oligonucleotides can be used to effectively inhibit Cas9 activity both ex vivo and in vitro .

Authors 9

  1. Wageningen University & Research

    Affiliation as printed

    Laboratory of Microbiology, Wageningen University and Research, Wageningen, The Netherlands; Delft, The Netherlands

    Delft, The Netherlands

  2. Peng Shang Aachen

    Leiden University · Leiden University Medical Center

    Affiliation as printed

    Department of Anatomy and Embryology, Leiden University Medical Centre, Leiden, The Netherlands; Delft, The Netherlands

    Delft, The Netherlands

  3. Wageningen University & Research

    Affiliation as printed

    Food Microbiology, Wageningen University and Research, Wageningen, The Netherlands; Delft, The Netherlands

    Delft, The Netherlands

  4. Wageningen University & Research

    Affiliation as printed

    Food Microbiology, Wageningen University and Research, Wageningen, The Netherlands; Delft, The Netherlands

    Delft, The Netherlands

  5. Niels Geijsen Aachen

    Leiden University · Leiden University Medical Center

    Affiliation as printed

    Department of Anatomy and Embryology, Leiden University Medical Centre, Leiden, The Netherlands; Delft, The Netherlands

    Delft, The Netherlands

  6. Delft University of Technology

    Affiliation as printed

    Department of Bionanoscience, Delft University of Technology, Delft, The Netherlands; and Delft, The Netherlands

    Kavli Institute of Nanoscience, Delft, The Netherlands

    Delft, The Netherlands

  7. Wageningen University & Research

    Affiliation as printed

    Laboratory of Microbiology, Wageningen University and Research, Wageningen, The Netherlands; Delft, The Netherlands

    Delft, The Netherlands

  8. Raymond H.J. Staals corresponding

    Wageningen University & Research

    Affiliation as printed

    Laboratory of Microbiology, Wageningen University and Research, Wageningen, The Netherlands; Delft, The Netherlands

    Delft, The Netherlands

  9. Richard A. Notebaart corresponding

    Wageningen University & Research

    Affiliation as printed

    Food Microbiology, Wageningen University and Research, Wageningen, The Netherlands; Delft, The Netherlands

    Delft, The Netherlands

Cited by 0 stored of 0

No patents citing this paper on Lens.org (checked 2026-10-11).

References 82